Optimizing Medication Adherence: Integrating Tools for Patient Compliance

Log-in / Register

Therapeutic Areas
Viatris Medicines
Medical News
Events
- On-Demand Videos
Healthy Conversations
ViatrisConnect Medical

Medical News
Health Connect
Pharmacist Connect
Optimizing Medication Adherence: Integrating Tools for Patient Compliance

Optimizing Medication Adherence: Integrating Tools for Patient Compliance

Source:
Mortelmans L, et al. Evaluation of methods measuring medication adherence in patients with polypharmacy: a longitudinal and patient perspective. Eur J Clin Pharmacol. 2024. doi: 10.1007/s00228-024-03661-1. Epub ahead of print. Approved Article: https://viatris-coe.s3.eu-central-1.amazonaws.com/general/gr/general/PHARMACIST_Evaluation_of_methods_measuring_medication_adherence_in_patients_with_polypharmacy.pdf

Music copyrights: 
Correle Carna by Cumbia Deli from YouTube Audio Library 
http://goo.gl/YmnOAx

MY-NON-2024-00102-30MAY24

Contact Us
Adverse Events Reporting
Medical Information
Privacy Policy
Terms of Use
Cookie Policy

Copyright © 2023 Viatris Inc. All Rights Reserved.

This website is intended for healthcare professionals in Malaysia. Adverse events should be reported to Viatris by email. To report an adverse event on Viatris brands, please click here. Reporting forms and information can be found here.

Leaving the site

You are now leaving the Viatris Malaysia page for a Viatris affiliate site or third-party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third-party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third-party sites are subject to their own terms and data protection notices and practices. Moreover, a third-party site is subject to other country laws, regulatory requirements, data protection requirements; medical practices may differ between countries and the information provided therein may not be suitable for use in your country.